Oramed Pharmaceuticals
ORMP
#9129
Rank
$0.16 B
Marketcap
$4.02
Share price
0.00%
Change (1 day)
88.73%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): $78.72 Million USD

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of $77.88 Million USD, an increase over its 2024 earnings that were of -$15.07 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $78.72 M1.08%
2025 $77.88 M-616.9%
2024 -$15.07 Million-311.47%
2023 $7.12 M-119.45%
2022 -$36.63 Million39.17%
2021 -$26.32 Million73.93%
2020 -$15.14 Million18.53%
2019 -$12.77 Million-16.62%
2018 -$15.32 Million38.32%
2017 -$11.07 Million12.51%
2016 -$9.84 Million25.01%
2015 -$7.87 Million18.18%
2014 -$6.66 Million39.72%
2013 -$4.77 Million46.4%
2012 -$3.26 Million128.32%
2011 -$1.43 Million-51.47%
2010 -$2.94 Million35.21%
2009 -$2.18 Million
2007 -$3.42 Million607.04%
2006 -$0.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
$25.01 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
$7.65 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-$0.54 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-$26.09 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
$34.88 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel